GPR56 interacts with extracellular matrix and regulates cancer progression

Advances in Experimental Medicine and Biology

Volumn 706, Issue , 2010, Pages 98-108

  Xu, Lei ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 56; LATROPHILIN; MESSENGER RNA; PROLINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SERINE; THREONINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN DEVELOPMENT; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE; GENE LOCATION; GENE STRUCTURE; GPR56 GENE; HUMAN; LUNG METASTASIS; MELANOMA CELL; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; START CODON; UPREGULATION;

ANIMALS; ANTIGENS, CD; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HUMANS; MUTATION; NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES;

EID: 79960774939     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7913-1_8     Document Type: Article

References (45)

1. Liu M, Parker RM, Darby K et al. GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics 1999; 55(3):296-305. (Pubitemid 29096131)
2. Zendman AJ, Cornelissen IM, Weidle UH et al. TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett 1999; 446(2-3):292-298. (Pubitemid 29132746)
3. XuL, Begum S, Hearn JD et al. GPR56, an atypical Gprotein- coupledreceptor,binds tissue transglutaminase, TG2 and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 2006; 103(24):9023-9028. (Pubitemid 43902526)
4. Li S, Jin Z, Koirala S et al. GPR56 regulates pial basement membrane integrity and cortical lamination. J Neurosci 2008; 28(22):5817-5826.
5. Piao X, Hill RS, Bodell A et al. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004; 303(5666):2033-2036. (Pubitemid 38393281)
6. Koirala S, Jin Z, Piao X et al. GPR56-regulated granule cell adhesion is essential for rostral cerebellar development. J Neurosci 2009; 29(23):7439-7449.
7. Yona S, Lin HH, Siu WO et al. Adhesion-GPCRs: Emerging roles for novel receptors. Trends Biochem Sci 2008; 33(10):491-500.
8. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008; 7(4):339-357.
9. Terskikh AV, Easterday MC, Li L et al. From hematopoiesis to neuropoiesis: Evidence of overlapping genetic programs. Proc Natl Acad Sci USA 2001; 98(14):7934-7939. (Pubitemid 32642665)
10. Terskikh AV, Miyamoto T, Chang C et al. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 2003; 102(1):94-101. (Pubitemid 36759641)
11. Jin Z, Tietjen I, Bu L et al. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 2007; 16(16):1972-1985. (Pubitemid 47354880)
12. Cyster J, Somoza C, Killeen N et al. Protein sequence and gene structure for mouse leukosialin (CD43), a T-lymphocyte mucin without introns in the coding sequence. Eur J Immunol 1990; 20(4):875-881. (Pubitemid 20167045)
13. Corral L, Singer MS, Macher BA et al. Requirement for sialic acid on neutrophils in a GMP-140 (PADGEM) mediated adhesive interaction with activated platelets. Biochem Biophys Res Commun 1990; 172(3):1349-1356.
14. Stacey M, Lin HH, Gordon S et al. LNB-TM7, a group of seven-transmembrane proteins related to family-B G-protein-coupled receptors. Trends Biochem Sci 2000; 25(6):284-289. (Pubitemid 30333387)
15. Krasnoperov VG, Bittner MA, Beavis R et al. Alpha-latrotoxin stimulates exocytosis by the interaction with aneuronal G-protein-coupled receptor. Neuron 1997; 18(6):925-937. (Pubitemid 27274611)
16. Lin H, Chang G, Davies J et al. Autocatalytic cleavage of the EMR2 receptor occurs at a conserved G protein-coupled receptor proteolytic site motif. JBC 2004; 279(30): 31823-31832. (Pubitemid 39037855)
17. Paulus H. Protein splicing and related forms of protein autoprocessing. Annu Rev Biochem 2000; 69:447-496.
18. Krasnoperov V, Bittner MA, Holz RW et al. Structural requirements for alpha-latrotoxin binding and alpha-latrotoxin-stimulated secretion. A study with calcium-independent receptor of alpha-latrotoxin (CIRL) deletion mutants. J Biol Chem 1999; 274(6):3590-3596. (Pubitemid 29077201)
19. Xu L, Hynes RO. GPR56 and TG2: Possible roles in suppression of tumor growth by the microenvironment. Cell Cycle 2007; 6(2):160-165. (Pubitemid 46232496)
20. Fidler IJ. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3(6):453-458. (Pubitemid 37328849)
21. Morrison SJ, Spradling AC. Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life. Cell 2008; 132(4):598-611. (Pubitemid 351253690)
22. Shashidhar S, Lorente G, NagavarapuU et al. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005; 24(10):1673-1682. (Pubitemid 40461124)
23. Sud N, Sharma R, Ray R et al. Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett 2006; 233(2):265-270. (Pubitemid 43327382)
24. Ke N, Sundaram R, Liu G et al. Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 2007; 6(6): 1840-1850. (Pubitemid 46954061)
25. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9(4):239-252.
26. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007; 5(Suppl 1):32-40. (Pubitemid 46964284)
27. Lorand L, Graham RM. Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4(2):140-156. (Pubitemid 36172696)
28. Kotsakis P, Griffin M. Tissue transglutaminase in tumour progression: Friend or foe? Amino Acids 2007: 33(2):373-384. (Pubitemid 47222962)
29. Haroon ZA, Lai TS, Hettasch JM et al. Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth. Lab Invest 1999; 79(12):1679-1686. (Pubitemid 30013931)
30. Mangala LS, Arun B, Sahin AA et al. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion. Mol Cancer 2005; 4:33.
31. Jones RA, Kotsakis P, Johnson TS et al. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 2006; 13(9):1442-1453. (Pubitemid 44210348)
32. Verderio E, Gaudry C, Gross S et al. Regulation of cell surface tissue transglutaminase: Effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem 1999; 47(11):1417-1432.
33. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 1993; 121(2):439-448. (Pubitemid 23110886)
34. Lorand L, Dailey JE, Turner PM. Fibronectin as a carrier for the transglutaminase from human erythrocytes. Proc Natl Acad Sci USA 1988; 85(4):1057-1059. (Pubitemid 18073959)
35. Akimov SS, Krylov D, Fleischman LF et al. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000; 148(4):825-838.
36. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001; 98(5): 1567-1576.
37. De Laurenzi V, Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol 2001; 21(1):148-155.
38. Nanda N, Iismaa SE, Owens WA et al. Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 2001; 276(23):20673-20678.
39. Little KD, Hemler ME, Stipp CS. Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: Central role of CD81 in facilitating GPR56-Galpha q/11 association. Mol Biol Cell 2004; 15(5):2375-2387. (Pubitemid 38580653)
40. Hemler ME. Targeting of tetraspanin proteins-potential benefits and strategies. Nat Rev Drug Discov 2008; 7(9):747-758.
41. Ikeyama S, Koyama M, Yamaoko MS et al. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993; 177(5):1231-1237. (Pubitemid 23117114)
42. Takeda T, Hattori N, Tokuhara T et al. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res 2007; 67(4):1744-1749. (Pubitemid 46383401)
43. Saito Y, Tachibana I, Takeda Y et al. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res 2006; 66(19):9557-9565. (Pubitemid 44623654)
44. Feigelson SW, Grabovsky V, Shamri R et al. The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow. J Biol Chem 2003; 278(51):51203-51212. (Pubitemid 38020357)
45. Iguchi T, Sakata K, Yoshizaki K et al. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway. J Biol Chem 2008; 283(21):14469-14478.